These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 391623)

  • 21. [Blood platelet function in patients with coronary disease after administration of acetylsalicylic acid and dipyridamole].
    Olszańska-Skorek T; Mazurowa A; Pełczyńska I; Chojnowski K; Hołub A; Drzewoski J
    Pol Tyg Lek; 1983 Feb; 38(9):269-72. PubMed ID: 6866846
    [No Abstract]   [Full Text] [Related]  

  • 22. Platelet deposition on human atherosclerotic lesions is decreased by low-dose aspirin in combination with dipyridamole.
    Sinzinger H; O'Grady J; Fitscha P
    J Int Med Res; 1988; 16(1):39-43. PubMed ID: 3350203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet inhibitors for TIAs. A review of prospective drug trial results.
    Ramirez-Lassepas M
    Postgrad Med; 1984 Apr; 75(5):52-62. PubMed ID: 6369285
    [No Abstract]   [Full Text] [Related]  

  • 24. Enteric-coated acetylsalicylic acid plus dipyridamole compared with anticoagulants in the prevention of ischemic events in patients with transient ischemic attacks.
    Eriksson SE
    Acta Neurol Scand; 1985 Jun; 71(6):485-93. PubMed ID: 4024860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspirin and other platelet-aggregation inhibiting drugs.
    Gallus AS
    Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet activation in acute cerebral ischaemia. Serial measurements of platelet function in cerebrovascular disease.
    Dougherty JH; Levy DE; Weksler BB
    Lancet; 1977 Apr; 1(8016):821-4. PubMed ID: 67334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The combination of acetylsalicylic acid and dipyridamole is more effective in secondary prevention following transient ischaemic attack or cerebral infarction: the debate is closed].
    Luijckx GJ; De Keyser JH
    Ned Tijdschr Geneeskd; 2006 Aug; 150(33):1812-4. PubMed ID: 16967590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients?
    Rouhl RP; Lodder J
    Expert Rev Neurother; 2008 Nov; 8(11):1661-5. PubMed ID: 18986236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial.
    ; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
    Lancet; 2006 May; 367(9523):1665-73. PubMed ID: 16714187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial.
    Dengler R; Diener HC; Schwartz A; Grond M; Schumacher H; Machnig T; Eschenfelder CC; Leonard J; Weissenborn K; Kastrup A; Haberl R;
    Lancet Neurol; 2010 Feb; 9(2):159-66. PubMed ID: 20060783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Superior efficacy of clopidogrel plus acetylsalicylic acid compared with extended-release dipyridamole plus acetylsalicylic acid in preventing arterial thrombogenesis in healthy volunteers.
    Cadroy Y; Thalamas C; Sakariassen K; Boneu B
    Thromb Res; 2005; 116(4):293-300. PubMed ID: 16038713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dipyridamole with aspirin is better than aspirin alone in preventing vascular events after ischaemic stroke or TIA.
    Sudlow C
    BMJ; 2007 Apr; 334(7599):901. PubMed ID: 17463463
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of chronic proliferative glomerulonephritis using acetylsalicylic acid and dipyridamole].
    Knotková V; Petrů I; Nĕmecek K; Cieslar P; Pelèska J; Jáchymová M; Pick P; Tomasy M
    Cas Lek Cesk; 1989 Jun; 128(26):814-8. PubMed ID: 2507156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of antiplatelet drugs on beta tg and PF4 levels in patients with transient ischemic attacks.
    Fabris F; Randi ML; Casonato A; Dal Bo Zanon R; Manzoni S; Tonin P; De Zanche L; Girolami A
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():263-5. PubMed ID: 2408445
    [No Abstract]   [Full Text] [Related]  

  • 35. Trends in usage of alternative antiplatelet therapy after stroke and transient ischemic attack.
    Hills NK; Johnston SC
    Stroke; 2008 Apr; 39(4):1228-32. PubMed ID: 18323509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effect of acetylsalicylic acid on platelet function in patients with completed stroke or reversible ischemic neurologic deficit.
    Lee TK; Chen YC; Lien IN; Liu MC; Huang ZS
    Stroke; 1988 May; 19(5):566-70. PubMed ID: 3363589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Secondary prevention after stroke. 2 platelet inhibitors are better than one].
    MMW Fortschr Med; 2002 May; 144(19):61. PubMed ID: 12116558
    [No Abstract]   [Full Text] [Related]  

  • 38. Aspirin in transient ischemic attacks and minor stroke: a meta-analysis.
    Stachenko SJ; Bravo G; Côté R; Boucher J; Battista RN
    Fam Pract Res J; 1991 Jun; 11(2):179-91. PubMed ID: 1829313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J
    J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharma-clinics. The drug of the month. Dipyridamole-acetylsalicylic acid combination (Aggrenox)].
    Scheen AJ
    Rev Med Liege; 2000 Oct; 55(10):957-9. PubMed ID: 11244807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.